Skip to main content

Table 3 Multivariate logistic regression analysis of the influence of five biochemical markers on patients with HF

From: Evaluating the link between DIO3-FA27 promoter methylation, biochemical indices, and heart failure progression

Variables

Case

Group

β-value

SE

P-value

OR

95% CI

Coagulation indicators

APTT

10

Q1

Reference

–

–

–

–

10

Q2

− 1.17

1.66

0.48

0.31

0.01–8.05

10

Q3

3.30

1.64

0.04

27.00

1.08–674.12

10

Q4

5.58

2.17

0.01

264.04

3.76–18,548.4

FDP

10

Q1

Reference

–

–

–

–

10

Q2

− 6.65

2.15

0.00

0.00

0.00–0.09

10

Q3

− 3.95

1.72

0.02

0.02

0.00–0.57

10

Q4

− 3.49

1.72

0.04

0.03

0.00–0.90

Renal indicators

Urea

10

Q1

Reference

–

–

–

–

10

Q2

0.41

0.90

0.65

1.50

0.26–8.82

10

Q3

− 2.20

1.23

0.07

0.11

0.01–1.24

10

Q4

1.39

1.01

0.17

4.00

0.55–29.10

Blood routine indicators

MCV

10

Q1

Reference

–

–

–

–

10

Q2

− 2.20

1.23

0.07

0.11

0.01–1.24

10

Q3

− 2.60

1.24

0.04

0.07

0.00–0.84

10

Q4

− 3.58

1.32

0.00

0.03

0.00–0.37

Lipid indicators

HDL

10

Q1

Reference

–

–

–

–

10

Q2

1.35

1.26

0.28

3.86

0.33–45.57

10

Q3

3.05

1.26

0.02

21.00

1.78–248.10

10

Q4

4.40

1.49

0.00

81.00

4.36–1504.46

Liver indicators

ALP

10

Q1

Reference

–

–

–

–

10

Q2

− 0.54

1.05

0.61

0.58

0.08–4.56

10

Q3

− 1.80

1.02

0.08

0.17

0.02–1.23

10

Q4

− 3.39

1.32

0.08

0.03

0.00–0.37